Presentation is loading. Please wait.

Presentation is loading. Please wait.

Barr Laboratories, Inc. ‘PLAN B’ AND THE POLITICS OF THE FDA: Influencing the decision to allow emergency contraception to be sold over-the-counter for.

Similar presentations


Presentation on theme: "Barr Laboratories, Inc. ‘PLAN B’ AND THE POLITICS OF THE FDA: Influencing the decision to allow emergency contraception to be sold over-the-counter for."— Presentation transcript:

1 Barr Laboratories, Inc. ‘PLAN B’ AND THE POLITICS OF THE FDA: Influencing the decision to allow emergency contraception to be sold over-the-counter for women

2 What is Plan B? A form of emergency contraception -Blocks the hormone progesterone, which helps maintain pregnancies -Contains a higher dose of regular hormonal birth control pills that prevent pregnancy Currently available to ALL women as a prescription drug When taken within 72 hours of unprotected intercourse, can reduce the risk of pregnancy by 89% Available over-the-counter (OTC) in seven states 102 countries have it available OTC, 34 of which do not require prescription NOT the same as RU-486

3 Plan B and the FDA 1999: FDA approves Plan B as a prescription medication April 2003: Barr submits application to FDA requesting that Plan B be made available without a prescription for women Dec. 2003: FDA’s drug advisory committee votes 23-4 to recommend OTC sale May 2004: FDA rejects Barr’s initial application o July 2004: Barr submits second application proposing market of Plan B as prescription-only to girls under 16 and OTC status to older users July 18, 2005: Lester Crawford confirmed as FDA Commissioner Aug. 26, 2005: Crawford asks for 60-day comment period from public Aug. 31, 2005: Susan Wood, director of FDA’s Office of Women’s Health quits Sept. 28, 2005: Lester Crawford, FDA Commissioner resigns

4 STRATEGY Coalition Building Diversify Political Support Advocate Policy Alternatives Trump Opposition

5 COALITION BUILDING Advocacy Groups ▪ American Civil Liberties Union (ACLU) ▪ Feminist Majority Foundation ▪ Society for Women’s Health Research ▪ Morning-After Pill Conspiracy (MAP) Associations ▪ American College of Obstetricians and Gynecologists ▪ American Medical Association ▪ American Medical Women’s Association ▪ American Society for Emergency Contraception ▪ Association of Reproductive Health Professionals (ARHP) ▪ National Family Planning and Reproductive Health Association ▪ Pharmaceutical Manufactures Association NGO’s ▪ National Organization for Women (NOW) ▪ NARAL ▪ National Women’s Health Network ▪ National Women’s Law Center ▪ Planned Parenthood Federation of America ▪ Pro-Choice America Research ▪ The Reproductive Health Technologies Project (RHTP) ▪ Family Health Research ▪ Women’s Information Network

6 DIVERSIFY POLITICAL SUPPORT Senator Patty Murray (D- Washington) Senator Barbara Mikulski (D- Maryland) Senator Hillary Clinton (D- New York) Senator Carolyn Maloney (D- New York) Senator Edward Kennedy (D- Massachusetts) Senate Committee on Health, Education, Labor, and Pension (HELP) -Chairman: Michael Enzi (R- Wyoming) Senators Ted Stevens & Lisa Murkowski (R- Alaska) Senators Barbara Boxer & Dianne Feinstein (D- California) Senators Daniel Akaka & Daniel Inouve (D- Hawaii) Senators Susan Collins & Olympia Snowe (R- Maine) Senators Jeff Bingaman & Pete Domenici (D,R- New Mexico) Senators Judd Gregg & John Sununu (R- New Hampshire) Senators Maria Cantwell & Patty Murray (D- Washington) If members are willing to support Barr, the firm can allocate funds towards each Senator’s campaign re-election.

7 POLICY ALTERNATIVES Promote a non-political appointment for head of the FDA Before receiving Senate confirmation, the nominee for FDA commissioner must explain his/her values affecting their decision regarding approval of Plan B Pressure the Bush Administration to submit a nominee before the end of the year that supports the belief that the FDA remains a science-based organization Compel the Government Accountability Office to investigate the FDA’s handling of Plan B

8 TRUMP OPPOSITION Leading opposition groups to Plan B’s approval include: American Life League Concerned Women for America Catholic Medical Association American Association of Pro-Life Obstetricians and Gynecologists Opponents argue against over-the-counter approval of the emergency contraceptive because: 1) Want to restrict access to the drug 2) Believe it encourages promiscuity 3) Causes abortions 4) Think it is not safe o Implement a mass media campaign to debunk myths regarding Plan B o Target Senators from states where Plan B is given OTC o Build on the volume of Opinion/Editorials that have been written in support of Plan B o Advertising, media releases, coalition building

9 C O N C L U S I O N Plan B is a consumer pharmaceutical product that needs to be marketed as an OTC drug Barr should implement a nonmarket strategy that entails: Coalition Building Political Support Policy Alternatives A Refute Against Opposing Arguments


Download ppt "Barr Laboratories, Inc. ‘PLAN B’ AND THE POLITICS OF THE FDA: Influencing the decision to allow emergency contraception to be sold over-the-counter for."

Similar presentations


Ads by Google